nilutamide has been researched along with Adenoma, Prostatic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chauhan, G | 1 |
| Mehta, A | 1 |
| Gupta, S | 1 |
| Benassayag, E | 1 |
| Namer, M | 1 |
1 review available for nilutamide and Adenoma, Prostatic
| Article | Year |
|---|---|
Clinical applications of antiandrogens.
Topics: Androgen Antagonists; Breast Neoplasms; Cyproterone; Cyproterone Acetate; Female; Flutamide; Humans; | 1988 |
1 trial available for nilutamide and Adenoma, Prostatic
| Article | Year |
|---|---|
[Indications of antiandrogens in benign hyperplasia of the prostate].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Cyproterone Acetate; Flutamide; Humans; Imidazoles; I | 1995 |
1 other study available for nilutamide and Adenoma, Prostatic
| Article | Year |
|---|---|
Stromal-AR influences the growth of epithelial cells in the development of benign prostate hyperplasia.
Topics: Androgen Antagonists; Cell Proliferation; Cells, Cultured; Culture Media, Conditioned; Epithelial Ce | 2020 |